About
Cancer diagnosis
Areas of Focus
Categories
DiagnosticsChina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
3
As Collaborator
3
Total Enrollment
876
By Phase
PHASE2: 1PHASE1: 2NA: 2
By Status
NOT_YET_RECRUITING: 2ACTIVE_NOT_RECRUITING: 2COMPLETED: 1UNKNOWN: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05265052Lead Sponsor
3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
PHASE2Not yet recruiting
177 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2025
NCT05320809Lead Sponsor
Study of 3D189 in Patients With Hematologic Malignancies
PHASE1Active, not recruiting
15 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2026
NCT05218759Collaborator
Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC
NANot yet recruiting
30 participants
Started: Feb 21, 2022 · Completed: Oct 31, 2025
NCT04941313Lead Sponsor
Phase 1 Study of 3D229 in Healthy Subjects
PHASE1Completed
24 participants
Started: Jul 27, 2021 · Completed: Feb 21, 2022
NCT04584008Collaborator
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics
NAActive, not recruiting
600 participants
Started: Sep 23, 2020 · Completed: Mar 31, 2025
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...